February 26, 2025
Feb. 25, 2025 — The FDA has approved a new treatment plan for a long-acting injection, making it easier for people with moderate to severe opioid […]
February 24, 2025
The US Food and Drug Administration (FDA) has approved the first adaptive deep brain stimulation (aDBS) system for Parkinson’s disease (PD) that self-adjusts therapy to individual […]
February 24, 2025
The first platform trial for amyotrophic lateral sclerosis (ALS), which individually evaluated four experimental drugs, failed to meet key primary endpoints. Still, investigators view the trial […]
February 21, 2025
The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending fenfluramine (Fintepla) for treating seizures associated with Lennox-Gastaut syndrome. The recommendation […]
February 21, 2025
TOPLINE: Difficulty distinguishing spoken words from background noise, called speech-in-noise hearing impairment, was associated with increased risk for Parkinson’s disease (PD), with a 57% elevation in […]
February 21, 2025
Prenatal and early life sun exposure was associated with lower risk for relapse in children with pediatric-onset multiple sclerosis (MS), a new prospective cohort study showed. […]
February 19, 2025
Accumulations of microplastics and nanoplastics (MNPs) in the brain rose from 2016 to 2024 and were found in higher levels in the brain than in other […]
February 19, 2025
TOPLINE: Virtual reality (VR) technology was associated with enhanced balance and limb motor functions in critically ill adult patients compared with traditional rehabilitation techniques, new meta-analysis […]
February 17, 2025
Epidural steroid injections (ESIs) offer limited effectiveness in reducing back pain and disability, an updated review by the American Academy of Neurology (AAN) suggested. “They may […]